Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neoplasms × denileukin diftitox × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Conditions

Recurrence 1 Neoplasms 1

Interventions

Bone Marrow Transplantation 2 3-Iodobenzylguanidine 2 vorasidenib 1 tucatinib 1 tovorafenib 1 taletrectinib 1 olaparib 1 nirogacestat 1 glucarpidase 1 enzalutamide 1 denileukin diftitox 1 copanlisib 1 balstilimab 1 atezolizumab 1 adagrasib 1 Proton Pump Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 LY3023414 1 Hydrocortisone 1 Crizotinib 1 Carboxypeptidases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432483 2015-01-26

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

Eisai Inc.

No longer available

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡